Skip to main content

Fullcircle Wealth LLC

SEC CIK
0002030910
Latest filing
Nov 5, 2025

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by Fullcircle Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overviewAll 13F holders of RXRXFull Q3 2025 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2024
Holdings of RXRX by Fullcircle Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−17,405−100.0%Sold outHolders
Q1 202517,405$101.6K<0.1%+1,250+7.7%AddedHolders
Q4 202416,155$137.3K0.1%+16,155NewHolders